IL-10 suppresses cell surface CD23/FcεRII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes

Yodoi J, Hosoda M, Takami M, Kawabe T: Regulation of the expression of FcεR2 and IgE-BF. Chem Immunol 47:106–127, 1989 Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY: CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505–507, 1992 Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zybark C, Bonnefoy JY: CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3:119–125, 1995 Yokota A, Kikutani H, Tanaka T, Sato R, Barsumian EL, Suemura M, Kishimoto T: Two species of human Fcε receptor II (FcεRII/CD23): Tissue-specific and IL-4-specific regulation of gene expression. Cell 55:611–618, 1988 Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M: The low-affinity receptor for IgE. Immunol Rev 125:77–97, 1992 Capron A, Dessaint JP, Capron M, Joseph M, Ameisen JC, Tonnel AB: From parasites to allergy: The second receptor for IgE (FcεR2). Immunol Today 7:15, 1986 Borish L, Mascali JJ, Rosenwasser LJ: IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 146:63–67, 1991 Paul EN, Kolb JP, Abadie A, Gordon J, Delespesse G, Sarfati M, Mencia-Huerta JM, Braquet P, Dugas B: Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes. J Immunol 149:3066–3071, 1992 Mossalayi MD, Lecron JC, Dalloul AH, Sarfati M, Bertho JM, Hofstetter H, Delespesse G, Debre P: Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med 171:959–964, 1990 Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, MacLennan IC: Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: Evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21:1107–1114, 1991 Armant M, Ishihara H, Rubio M, Delespesse G, Sarfati M: Regulation of cytokine production by soluble CD23: Costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release. J Exp Med 180:1005–1011, 1994 Herbelin A, Elhadad S, Ouaaz F, de Groote D, Descamps-Latscha B: Soluble CD23 potentiates interleukin-1-induced secretion of interleukin-6 and interleukin-1 receptor antagonist by human monocytes. Eur J Immunol 24:1869–1873, 1994 Vercelli D, Jabara HH, Lee BW, Woodland N, Geha RS, Leung DYM: Human recombinant Interleukin 4 induces FcεR2/CD23 on normal human monocytes. J Exp Med 167:1406–1416, 1988 Alderson MR, Tough TW, Ziegler SF, Armitage RJ: Regulation of human monocyte cell-surface and soluble CD23 (FcεRII) by granulocyte-macrophage colony-stimulating factor and IL-3. J Immunol 149:1252–1257, 1992 te Velde AA, Rousset F, Peronne C, de Vries JE, Figdor CG: IFN-α and IFN-γ have different regulatory effects on IL-4-induced membrane expression of FcεRIIb and release of soluble FcεRIIb by human monnocytes. J Immunol 144:3052–3059, 1990 Hashimoto S, Koh K, Tomota Y, Amemiya E, Sawada S, Yodoi J, Horie T: TNFα regulates IL-4-induced FcεRII/CD23 gene expression and soluble FcεRII release by human monocytes. Int Immunol 7:705–713, 1995 Spitter A, Schiller C, Willheim M, Tempter C, Winkler S, Boltz-Nitulescu G: IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: Effects of IL-10 and other cytokines on cell phenotype and phagocytosis. Immunology 85:311–317, 1995 Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88:1172–1176, 1991 de Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220, 1991 de Waal-Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915–924, 1991 Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, de Boer M, Goldman M: Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24:1007–1009, 1994 Kawabe T, Takami M, Hosoda M, Maeda Y, Sato S, Mayumi M, Mikawa H, Arai K, Yodoi J: Regulation of FcεR2/CD23 gene expression by cytokines and specific ligand (IgE and anti-FcεR2 monoclonal antibody). Variable regulation depending on the cell types. J Immunol 141:1376–1382, 1988 Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987 Siebert PD, Larrick JW: Competitive PCR. Nature 359:557–558, 1992 te Velde AA, de Waal-Malefyt R, Huijbens RJ, de Vries JE, Figdor CG: IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 149:4048–4052, 1992 Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890–1893, 1992 Pforte A, Breyer G, Prinz JC, Gais P, Burger G, Haussinger K, Rieber EP, Held E, Ziegler HH: Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitis. J Exp Med 171:1163–1169, 1990 Williams J, Johnson S, Mascali JJ, Smith H, Rosenwasser LJ, Borish L: Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol 149:2823–3829, 1992 Becker H, Potyka P, Weber C, Federlin K: Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases. Clin Exp Immunol 85:61–65, 1991 Yoshikawa T, Nanba T, Kato H, Hori K, Inamoto T, Kumagai S, Yodoi J: Soluble FcεRII/CD23 in patients with autoimmune disease and Epstein-Barr virus related disorders: Analysis by ELISA for soluble FcεRII/CD23. Immunomethods 4:65–71, 1994 Kumagai S, Ishida H, Iwai K, Tsubata T, Umehara H, Ozaki S, Suginoshita T, Araya S, Imura H: Possible different mechanism of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: Opposite expression of low affinity receptors for IgE (CD23) on their peripheral B cells. Clin Exp Immunol 78:348–353, 1989 Plater-Zyberk C, Bonnefoy JY: Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nature Med 1:781–785, 1995